Baishen Pan
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diet, Metabolism, and Disease
- Diabetes Treatment and Management
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Cancer, Lipids, and Metabolism 9
- Cancer Genomics and Diagnostics 5
- Hepatology 10
- Hepatocellular Carcinoma Treatment and Prognosis 7
Baishen Pan
85 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 116
- Endocrinology, Diabetes and Metabolism 452
- Hepatology 162
- Physiology 90
- Cancer Research 254
- Epidemiology 406
Countries citing papers authored by Baishen Pan
This map shows the geographic impact of Baishen Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baishen Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baishen Pan more than expected).
Fields of papers citing papers by Baishen Pan
This network shows the impact of papers produced by Baishen Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baishen Pan. The network helps show where Baishen Pan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Baishen Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 3 | |
| 13 | 2022 | 3 | |
| 14 | 2022 | 13 | |
| 15 | 2022 | 26 | |
| 16 | 2021 | 23 | |
| 17 | 2021 | 6 | |
| 18 | 2020 | 15 | |
| 19 | 2010 | 1 | |
| 20 | 2009 | 1 |
About Baishen Pan
Baishen Pan is a scholar working on Cancer Research, Hepatology, Oncology, Hematology and Endocrinology, Diabetes and Metabolism, having authored 89 papers that have together received 1.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Cancer, Lipids, and Metabolism (9 papers), Immune Cell Function and Interaction (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Cancer Genomics and Diagnostics (5 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (452 citations), Hepatology (162 citations), Physiology (90 citations), Cancer Research (254 citations) and Epidemiology (406 citations). Baishen Pan has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Beili Wang, Wei Guo, Xin‐Rong Yang, Mingfeng Xia, Jia Fan, Xin Gao, Wei Guo, Xiaolu Ma, Hui Ma and Huandong Lin. Their work appears in journals such as Journal of Clinical Laboratory Analysis, Clinica Chimica Acta, PLoS ONE, Journal of Clinical Oncology and Lipids in Health and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.